Policy | July 27, 2022
Pharmaceuticals industry under Atmanirbhar Bharat programme
India exported about Rs 33,321 crore and imported Rs 35,249 crore worth APIs and Bulk drugs in 2021-22.
India exported about Rs 33,321 crore and imported Rs 35,249 crore worth APIs and Bulk drugs in 2021-22.
The approval has been accorded by IFCI Limited for manufacturing of the product "7 ACA"
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
Nippon Express has provided a pharmaceutical distribution platform with strict temperature control in two ranges -- 2 C to 8 C
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Subscribe To Our Newsletter & Stay Updated
